Postinor tablets 0.75 mg blister 2 pcs.

The active substance is levonorgestrel (one tablet contains 0.75 mg of levonorgestrel).

Excipients: colloidal anhydrous silicon dioxide, potato starch, magnesium stearate, talc, corn starch, lactose monohydrate.

Hypersensitivity to the active substance (levonorgestrel) or to any of the excipients.

It is necessary to use two tablets.

Both tablets should be taken together as soon as possible, preferably within 12 hours and no later than 72 hours after unprotected sex.

If vomiting occurs within 3 hours of taking the tablets, two more tablets should be taken immediately.

Women who have taken enzyme-inducing drugs within the last 4 weeks and who need emergency contraception are advised to use non-hormonal emergency contraception methods, i.e., the copper IUD, or to take a double dose of levonorgestrel (i.e., 4 tablets at the same time) for women who cannot or do not want to use the copper IUD.

“Postinor” can be used in any phase of the menstrual cycle if there is no delay in menstrual bleeding.

After using emergency contraception, it is recommended to use a local barrier method (e.g. condoms, diaphragms, spermicide, cervical cap) until the start of the next menstruation. The use of the drug “Postinor” is not a contraindication for continuing regular hormonal contraception.

For oral use.

Pregnant women

Pregnant women should not use Postinor. The drug does not cause abortion. In the event of continued pregnancy, according to limited epidemiological data, no adverse effects on the fetus have been observed. At the same time, there is no clinical data on possible consequences when using a dose exceeding 1.5 mg of levonorgestrel.

Levonorgestrel is excreted in breast milk. The potential exposure of the infant to levonorgestrel can be reduced if the breastfeeding woman takes the tablets immediately after feeding, avoiding feeding for at least 8 hours after each dose of Postinor.

Levonorgestrel increases the possibility of menstrual irregularities, which in some cases lead to earlier or later ovulation. These changes may affect the dates of the fertile period, but there are no data on fertility with long-term follow-up.

Children

“Postinor” is not intended for use in adolescents for emergency contraception.

Drivers

The effect of the drug on the ability to drive vehicles or other complex mechanisms has not been studied.

No serious adverse effects have been reported after acute overdose with large doses of oral contraceptives. In case of overdose, nausea and breakthrough bleeding are possible. There is no specific antidote, treatment is symptomatic.

The most common adverse effect was nausea.

Store at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life – 5 years.